Table 5.
Prevalence of antibiotic classes for infection categories expressed as % of total number of antibiotic prescriptions.
| Number of patients | Any infection 2708 | Pneumonia 958 | Tracheobronchitis 170 | Urogenital infection 1132 | Other infection 330 | Uncertain infection 490 |
|---|---|---|---|---|---|---|
| Number of antibiotic prescriptions | 5237 | 1862 | 233 | 1723 | 650 | 769 |
| Antibiotic class, n (%) | ||||||
| Lincosamides and tetracyclines | ||||||
| Tetracyclines | 33 (0.6%) | 10 (0.5%) | 9 (3.9%) | 1 (<0.1%) | 13 (2%) | 0 |
| Lincosamides | 186 (3.6%) | 124 (6.7%) | 3 (1.3%) | 10 (0.6%) | 15 (2.3%) | 34 (4.4%) |
| Cephalosporins, carbapenems, monobactams | ||||||
| Cephalosporins | 986 (18.8%) | 436 (23.4%) | 45 (19.3%) | 216 (12.5%) | 125 (19.2%) | 164 (21.3%) |
| Carbapenems | 90 (1.7%) | 49 (2.6%) | 2 (0.9%) | 13 (0.8%) | 18 (2.8%) | 8 (1.0%) |
| Monobactams | 11 (0.2%) | 1 (<0.1%) | 0 | 2 (0.1%) | 6 (0.9%) | 2 (0.3%) |
| Aminoglycosides | 208 (4%) | 82 (4.4%) | 9 (3.9%) | 33 (1.9%) | 56 (8.6%) | 28 (3.6%) |
| Fluoroquinolones | 1129 (21.6%) | 244 (13.1%) | 50 (21.5%) | 651 (37.8%) | 66 (10.2%) | 118 (15.3%) |
| Penicillins | 433 (8.3%) | 138 (7.4%) | 15 (6.4%) | 164 (9.5%) | 64 (9.9%) | 52 (6.8%) |
| Penicillin plus β-lactamase inhibitors | 1082 (20.7%) | 456 (24.5%) | 80 (34.3%) | 179 (10.4%) | 83 (12.8%) | 284 (36.9%) |
| Other | ||||||
| Glycopeptides | 184 (3.5%) | 74 (4.0%) | 1 (0.4%) | 17 (1%) | 67 (10.3%) | 25 (3.3%) |
| Metronidazole | 301 (5.7%) | 151 (8.1%) | 2 (0.9%) | 24 (1.4%) | 96 (14.8%) | 28 (3.6%) |
| Nitrofurans | 60 (1.1%) | 0 | 0 | 58 (3.4%) | 0 (0) | 2 (0.3%) |
| Sulphonamides/folic acid inhibitors | 372 (7.1%) | 9 (0.5%) | 2 (0.9%) | 346 (20.1%) | 8 (1.2%) | 7 (0.9%) |
| Macrolides | 162 (3.1%) | 88 (4.7%) | 15 (6.4%) | 9 (0.5%) | 33 (5.1%) | 17 (2.2%) |